HALO earnings call for the period ending March 31, 2019.
News & Analysis: Halozyme Therapeutics
Find out why these oncology-focused companies stand out as great opportunities right now.
HALO earnings call for the period ending December 31, 2018.
Shares fall after an analyst lowers his price target. Here's what investors need to know.
Just because investors are ignoring these three gems doesn't mean that you have to.
Investors cheer better-than-expected earnings and a guidance boost. Could there be more upside ahead?
Halozyme Therapeutics, FMC Corp., and Braskem all have major opportunities in front of them that could lead to outsize returns.
Big pharma companies have thrown hundreds of millions of dollars at this small biotech. Should retail investors follow suit?
Prospects for two of this week's big healthcare winners look great. But it's a different story for one of them.
The stock market was mixed, but these stocks climbed. Find out why.